美容注射剂的全球市场 - 市场规模(各市场区隔)，占有率，法规，偿付，治疗，预测(～2033年)

本报告提供全球美容注射剂市场相关调查分析，提供主要企业与市场占有率，主要趋势，创新的产品与技术，竞争情形等资讯。

市场模式的主要内容如下列。

已上市的美容注射剂与不断变化的竞争格局

• 主要的产业趋势考察
• 按美容注射剂市场区隔的年度收益与市场预测(2015年～2033年)
• 有关各市场区隔的整体治疗数，台数，平均销售价格，市场金额的详细资料

世界，地区，国家层级的市场固有考察

• 各地区分类的全球趋势之特定市场定性资讯和国家/地区考察
• 美容注射剂市场SWOT分析
• 美容注射剂市场竞争动态的考察和趋势

透过对医疗保健系统的真实、全面的了解来促进市场了解。市场进入部分还提供有关报销政策和监管环境的信息，使您能够更深入地研究市场动态。

• 各国医疗制度概要
• 各国偿付政策
• 各国医疗技术相关法规形势

对象企业

• Allergan Aesthetics
• Galderma SA
• Merz Pharma GmbH & Co KgaA
• Sinclair Pharma Ltd
• Teoxane SA
• 其他

Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Aesthetic Devices therapeutic area.

Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. This is achieved by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. Aesthetic Injectables are rising in popularity, due to the non-surgical and non-invasive nature of these procedures. In addition, successful outcomes are achieved quickly with limited recovery time.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Aesthetic Injectables and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Aesthetic Injectables market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices, and market values by segment.

Global, Regional, and Country level market specific insights -

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Aesthetic Injectables market.
• Competitive dynamics insights and trends provided for the Aesthetic Injectables market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Allergan Aesthetics, Galderma SA, Merz Pharma GmbH & Co KgaA, Sinclair Pharma Ltd, Teoxane SA, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Aesthetic Injectables marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Aesthetic Injectables market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Aesthetic Injectables market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Aesthetic Injectables market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.